Document Detail

Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome.
MedLine Citation:
PMID:  22818785     Owner:  NLM     Status:  Publisher    
Early and adequate risk stratification is essential in patients with suspected acute coronary syndrome (ACS). The aim of the present study was to investigate whether glycogen phosphorylase BB (GPBB) could add prognostic information in the context of contemporary sensitive troponin I determination and B-type natriuretic peptide (BNP). Patients with suspected ACS were consecutively enrolled at 3 German study centers from January 2007 through December 2008. Troponin I, GPBB, and BNP were determined at admission. Follow-up information on the combined end point of death, myocardial infarction, revascularization, and hospitalization owing to a cardiovascular cause was obtained 6 months after enrollment. In total 1,818 patients (66% men) were enrolled of whom 413 (23%) were diagnosed as having acute myocardial infarction and 240 (13%) as having unstable angina pectoris, whereas in 1,165 patients (64%) an ACS could be excluded. Follow-up information was available in 98% of patients; 203 events were registered. GPBB measured on admission predicted an unfavorable outcome with a hazard ratio of 1.24 (p <0.05) in an unadjusted Cox regression model and showed a tendency with a hazard ratio of 1.13 (p = 0.07) in a fully adjusted model. Kaplan-Meier analysis revealed a poorer outcome in patients with increased GPBB levels amendatory to the information provided by troponin I or BNP. In conclusion, GPBB measurement provides predictive information on midterm prognosis in patients with chest pain in addition to BNP and troponin I.
Lars Lillpopp; Stergios Tzikas; Francisco Ojeda; Tanja Zeller; Stephan Baldus; Christoph Bickel; Christoph R Sinning; Philipp S Wild; Sabine Genth-Zotz; Ascan Warnholtz; Karl J Lackner; Thomas Münzel; Stefan Blankenberg; Till Keller
Related Documents :
1965405 - Beta- and alpha-adrenoceptor-agonists and -antagonists in chronic heart failure.
22863175 - Usefulness of hyponatremia in the acute phase of st-elevation myocardial infarction as ...
18221115 - Nebivolol: more than a highly selective beta blocker.
22513225 - Development of a virtual tool for monitoring quality of care in acute myocardial infarc...
2013185 - Normalization of reverse redistribution of thallium-201 with procainamide pretreatment ...
2145735 - Hypertensive heart disease: relationship of silent ischemia to coronary artery disease ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-17
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Department of Internal Medicine II, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Functional and hemodynamic cardiac determinants of exercise capacity in patients with systolic heart...
Next Document:  Cloning and characterization of histone deacetylase from Babesia bovis.